Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Clinical trial NCT05905172 · RECRUITING
Trial details
- NCT number
- NCT05905172
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-12
- Primary completion
- 2028-06-20
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.